B

Brandon Capital Partners

50 employees

Based in Melbourne, Australia, Brandon Capital Partners is a fund management business focused on investments in life science ventures.

Investor insights

Sectors invested in

Biotechnology19
Health Care15
Medical11
Therapeutics5
Medical Device5
Pharmaceutical4
Life Science3
Biopharma3
Health Diagnostics2
Wellness2
Medical Devices and Medical Technology1
Polymer Chemistry1
Ophthalmology1
Drug Delivery1
Clinical Trials1
Tropoelastin1
Elastin1

Funding rounds participated in

$1.5M sweet spot round size

Most of their 38 investments are in rounds between $5.9M and $24M

Investor type

Venture Capital

Basic info

Industry

investment management

Sectors

Biotechnology
Financial Services
Venture Capital

Date founded

2006

Investments made

E

Entact Bio raised $81M on December 6, 2022

Investors: Qiming Venture Partners USA, Logos Global Management, LP, Surveyor Capital, venBio Partners, Abingworth and Brandon Capital Partners

C

CatalYm GmbH raised $51M on November 22, 2022

Investors: coparion, JEITO, Vesalius Biocapital, BGV (BioGeneration Ventures), Forbion, Bayern Kapital GmbH and Brandon Capital Partners

-

- raised $18M on November 9, 2022

Investors: Omega Funds and Brandon Capital Partners

P

Pheon Therapeutics raised $68M on September 28, 2022

Investors: Research Corporation Technologies, Inc., Forbion, Atlas Venture and Brandon Capital Partners

O

OncoRes Medical raised $6.7M on May 18, 2022

Investors: Brandon Capital Partners

U

Undisclosed raised $7.1M on May 3, 2022

Investors: IP Group plc and Brandon Capital Partners

A

Allay Therapeutics raised $60M on September 15, 2021

Investors: Vertex Growth, Temasek, Vertex Ventures HC and Brandon Capital Partners

U

Undisclosed raised $24M on June 17, 2021

Investors: Stoic Venture Capital, Uniseed, Minderoo Foundation and Brandon Capital Partners

M

Myricx Pharma Ltd raised $5.9M on November 16, 2020

Investors: Sofinnova Partners and Brandon Capital Partners

U

Undisclosed raised $8.3M on September 28, 2020

Investors: CSL, Stoic Venture Capital, Uniseed, HESTA and Brandon Capital Partners

FAQ